Phone: (905) 525-9140 ext: 27542
Fax: (905) 524-0069
Office: IAHS Rm. 442
Dr. Bosch is an Associate Professor in the School of Rehabilitation Science. Her clinical interests are in the area of adult neurological rehabilitation and in particular, functional recovery post-stroke. She completed a Master's degree in Clinical Epidemiology at McMaster and a PhD in Rehabilitation Science. She divides her time between research in cardiovascular disease prevention and studies in improving function. In particular, Jackie is involved in large clinical trials in both primary and secondary prevention, and rehabilitation studies involving functional recovery post stroke
Concurrently Dr. Bosch has been involved in the Professional Roles and Experiential Practicum course in year one, and one of the evidence based practice courses in year two of the occupational therapy program.
Keywords: stroke recovery, motor function, clinical trials
Dr Bosch’s area of research is in motor recovery post stroke, clinical trials methodology and measuring function.
Dr. Jackie Bosch is currently not taking students for Academic Year 2019-2020.
Wald R, Rabbat CG, Girard L, Garg AX, Tennankore K, Tyrwhitt J, … Bosch J, et al. Two phosphAte taRGets in End-stage renal disease Trial (TARGET): a randomized controlled trial. Clin J Am Soc Nephrol. 2017;12(6)965-73.
Letts L, Bosch J. Measuring Occupational Performance in Basic Activities of Daily Living. In: Law M, Baum C, & Dunn W, editors. Measuring Occupational Performance: Supporting Best Practice in Occupational Therapy. 3rd ed. Thorofare, NJ: Slack Inc; 2017.
Kilickap M, Bosch J, Eikelboom JW, Hart RG. Antithrombotic treatments for stroke prevention in elderly patients with nonvalvular atrial fibrillation: drugs and doses. Can J Cardiol. 2016;32(9):1108-16.
Bhagirath VC, Bosch J, Eikelboom JW. Enhanced TRAP-induced platelet aggregation with dabigatran - clinical perspective. Thromb Res. 2016;138:61-2.
Yusuf S, Lonn E, Pais P, Bosch J, Lopez-Jaramillo P, Zhu J, et al. Blood-pressure and cholesterol lowering in persons without cardiovascular disease. N Engl J Med. 2016;374(21):2032-43.
Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, et al. Cholesterol lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med. 2016;374(21):2021-31.
Lonn EM, Bosch J, Lopez-Jaramillo P, Zhu J, Liu L, Pais P, et al. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med. 2016;374(21):2009-20.
Siegler JE, Swaminathan B, Giruparajah M, Bosch J, Perera KS, Hart RG, et al. Age disparity in diagnostic evaluation of stroke patients: Embolic Stroke of Undetermined Source Global Registry Project. European Stroke Journal. 2016;1(2):130-6.
Perera KS, Vanassche T, Bosch J, Swaminathan B, Mundl H, Giruparajah M, et al. Global survey of the frequency of atrial fibrillation–associated stroke: Embolic Stroke of Undetermined Source Global Registry. Stroke. 2016;47(9):2197-202.
Perera KS, Vanassche T, Bosch J, Giruparajah M, Swaminathan B, Mattina KR, et al. Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry. Int J Stroke. 2016;11(5):526-33.
Ageno W, Bosch J, Cucherat M, Eikelboom JW. (2016) Nadroparin for the prevention of venous thromboembolism in nonsurgical patients: a systematic review and meta-analysis. J Thromb Thrombolysis, 42(1), 90-98.
Eikelboom JW, Bosch J, Hart RG. Rapid reversal of haematoma expansion associated with vitamin K antagonists. Lancet neurol. 2016;15:535-7.
Raju N, Sobieraj-Teague M, Bosch J, Eikelboom JW. (2016) Updated meta-analysis of aspirin in primary prevention of cardiovascular disease. Am J Med, 129(5), e35-e36.